MEDA Co., Ltd. appears in FDA device records as the applicant behind a family of bladder scanner submissions. The most recent is K260313 for the MD-6000S Bladder Scanner, received January 30, 2026 and decided September 24, 2026 as substantially equivalent under product code IYO. Earlier records identify the MD-6000 and MD-6000P devices; the MD-6000P letter lists product codes IYO and ITX. The filings describe an ultrasonic pulsed echo imaging system regulated under 21 CFR 892.1560 in Class II. [1][6][7]
The 2026 MD-6000S clearance
K260313 covers the MD-6000S Bladder Scanner, a Traditional 510(k) with a Summary statement and no third-party review. The FDA record lists the advisory committee as Radiology and the decision description as Substantially Equivalent. The applicant address on the filing is in Tianjin, China, and the contact named is Linda Zhang. [1]
The device falls under product code IYO, mapped in the openFDA fields to the device name System, Imaging, Pulsed Echo, Ultrasonic, Class 2, regulation 892.1560, medical specialty Radiology. Those fields describe the regulatory category rather than the individual product's performance. [1]
Earlier MD-6000 and MD-6000P filings
A 510(k) summary for the MD-6000 Bladder Scanner, prepared October 9, 2011, describes the device as using pulse reflection and intended to measure the volume of a bladder filled with urine. It states the device is intended for use only by qualified medical professionals, with contraindications for fetal use and use on pregnant patients. [6]
The K182460 FDA letter, dated May 6, 2019, addresses the MD-6000P Bladder Scanner under regulation 21 CFR 892.1560, Class II, product codes IYO and ITX, and states the device was determined substantially equivalent. The same document lists the MD-6000 Bladder Scanner, K113304, as a predicate device manufactured by MEDA. [7]
Applicant identity and U.S. agent
The 2019 letter is addressed to Kai Chen as President of Meditech International, Inc., described as the United States Designated Agent of MEDA Co., Ltd. The 2011 summary names Kai Chen of Medtech International, Inc. as the U.S. designated agent. Both documents place the agent in Potomac, Maryland, while the applicant address is in Tianjin. [6][7]
These records identify MEDA as the applicant and Meditech or Medtech International as its designated agent. No parent company, brand owner or corporate website is verified in the available records, and the Tianjin filing address is not established as a headquarters. [1][6][7]
What the collection shows
The linked collection holds one 510(k) record, K260313, with a single SESE decision, and the record sample contains that same single entry. These counts describe the linked filings at the retrieval date, not total company sales, total portfolio or safety performance. [1]
A MAUDE adverse event report page carries the title MEDA CO., LTD BLADDER SCANNER under the ultrasonic imaging device description. The linked collection includes no recall records, and the available material does not establish clinical outcomes or comparative performance for any MEDA device. [4]

